Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 3,595 | 3,089 | 3,135 | 2,962 | 3,877 |
| Operating Income | -3,595 | -3,089 | -3,135 | -2,962 | -3,877 |
| Interest Expense | 0 | 0 | 261 | 592 | 1,211 |
| Other Income | -6,188 | -15,420 | 14,234 | 5,088 | 18,384 |
| Pre-tax Income | -9,783 | -18,509 | 10,838 | 1,534 | 13,296 |
| Income Tax | 416 | 1,133 | 1,634 | N/A | N/A |
| Net Income Continuous | -10,199 | -19,642 | 9,204 | 1,534 | 13,296 |
| Minority Interests | -10 | -23 | -8 | -2 | -256 |
| Net Income | $-10,189 | $-19,619 | $9,212 | $1,536 | $13,552 |
| EPS Basic Total Ops | -0.26 | -0.48 | 0.22 | 0.04 | 0.33 |
| EPS Basic Continuous Ops | -0.25 | -0.48 | 0.22 | 0.04 | 0.33 |
| EPS Diluted Total Ops | -0.26 | -0.48 | 0.22 | 0.04 | 0.33 |
| EPS Diluted Continuous Ops | -0.25 | -0.48 | 0.22 | 0.04 | 0.33 |
| EPS Diluted Before Non-Recurring Items | 0.01 | -0.48 | 0.22 | N/A | N/A |
| EBITDA(a) | $-3,564 | $-3,037 | $-3,081 | $-2,906 | $-3,824 |